Dr. Slatopolsky joined Washington University in 1963, where he was active in the research lab for over 50 years. His groundbreaking research paved the way for advancements in the treatment of kidney diseases, particularly in the management of secondary hyperparathyroidism in patients with chronic kidney disease, according to an April 29 university news release. He served as the inaugural director of the Chromalloy American Kidney Center, the first chronic dialysis center in St. Louis, and remained director for three decades.
He is survived by his three children and six grandchildren.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.